Tag: bioequivalence

bioavailability bioequivalence generic drugs brand drugs pharmacokinetics

How to Compare Bioavailability and Bioequivalence in Generic vs Brand Drugs

Bioavailability measures how much of a drug enters your bloodstream, while bioequivalence proves a generic matches the brand. Learn how regulators ensure generics work just as well - and when exceptions apply.

March 17 2026

NTI drugs generic substitution combination therapy bioequivalence therapeutic failure

Combination NTI Drugs and Generic Availability: Coverage and Gaps

Combination NTI drugs offer critical treatment for complex conditions, but generic versions are nearly nonexistent due to strict bioequivalence challenges. Patients face higher risks of failure and toxicity when substitutions occur.

March 12 2026

brand loyalty generic drugs pharmaceutical brands FDA regulations bioequivalence

Why Patients Prefer Brand-Name Medications Over Generics: Explained

This article explains why patients often prefer brand-name medications over cheaper generics despite identical effectiveness. It covers factors like perceived quality, trust, marketing influence, demographic trends, and real-world data from studies and surveys.

February 5 2026